Your session is about to expire
← Back to Search
Educational Tools for Cancer Clinical Trial Awareness
N/A
Recruiting
Led By Amelie G Ramirez, DrPH, MPH
Research Sponsored by The University of Texas Health Science Center at San Antonio
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients who have not had a consultation with their doctor to discuss treatment options
English or Spanish speaking
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 months after the index oncology visit
Awards & highlights
Study Summary
This trial is testing a way to increase awareness and positivity towards cancer clinical trials in order to get more people to participate.
Who is the study for?
This trial is for newly diagnosed cancer patients at the Mays Cancer Center who haven't yet discussed treatment options with their doctor and have never been in a clinical trial. Participants must be adults able to consent and speak English or Spanish.Check my eligibility
What is being tested?
The study tests a multi-communication approach, including an educational video, fact sheet, brochure, and navigator support to help people make informed decisions about joining cancer clinical trials.See study design
What are the potential side effects?
Since this trial focuses on educational materials rather than medical treatments, there are no direct physical side effects. However, participants may experience emotional or cognitive responses to the information provided.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I haven't discussed treatment options with my doctor yet.
Select...
I speak English or Spanish.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 3 months after the index oncology visit
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 months after the index oncology visit
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Proportion of patients who show intention to participate or to consider CTs as an appropriate treatment option for cancer.
Secondary outcome measures
Proportion of patients eligible for designated clinical trials who actually enroll in one of these trials.
Proportion of patients who show improved attitudes regarding CT participation.
Proportion of patients who show increase in knowledge/awareness regarding CT participation.
Trial Design
2Treatment groups
Active Control
Group I: Intervention GroupActive Control3 Interventions
Participants in the intervention group will receive 3 components: 1) a bilingual, culturally tailored clinical trial educational video, 2) a low literacy booklet, and 3) support from a patient navigator to empower cancer patients to make informed decisions about cancer clinical trial participation by increasing awareness of clinical trials and MCC services, positive attitudes and intentions to consider clinical trials as an appropriate treatment option for cancer.
Group II: Usual Care Control GroupActive Control1 Intervention
Participants in the usual care control group will receive a general clinical trial fact sheet.
Find a Location
Who is running the clinical trial?
The University of Texas Health Science Center at San AntonioLead Sponsor
451 Previous Clinical Trials
86,608 Total Patients Enrolled
Genentech, Inc.Industry Sponsor
1,538 Previous Clinical Trials
566,953 Total Patients Enrolled
Amelie G Ramirez, DrPH, MPHPrincipal InvestigatorUT Health San Antonio
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I haven't discussed treatment options with my doctor yet.You have previously taken part in a clinical trial.I am under 18 years old.I speak English or Spanish.You have never taken part in a clinical trial before.I am unable to understand and give consent for treatment.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention Group
- Group 2: Usual Care Control Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there currently any opportunities to join this experiment?
"The clinicaltrial.gov website reveals that this trial is not presently recruiting patients, as it was last updated on September 9th 2022. Notwithstanding the lack of recruitment for this particular study, 15 other trials are currently welcoming volunteers."
Answered by AI
Share this study with friends
Copy Link
Messenger